Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Peene

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Rheumatology|October 6, 2022
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
Seminars in Arthritis and Rheumatism|July 30, 2022
Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's SyndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
RMD Open|October 24, 2025
Ultrasound-guided core needle biopsy of the parotid gland in Sjögren's disease: a promising tool towards precision medicineHelena Achten, Eva Genbrugge, Liselotte Deroo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 30, 2024
Impact of IgG Fc Glycosylation on Disease Dynamics in Patients With Primary Sjögren DiseaseHelena Achten, Leander Meuris, Liselotte Deroo, et al.
Trials|June 5, 2020
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trialBastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, et al.
Trials|June 7, 2020
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trialCedric Bosteels, Bastiaan Maes, Karel Van Damme, et al.
Annals of the Rheumatic Diseases|April 17, 2026
Efgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO)Isabelle Peene, Gwenny M Verstappen, Suzanne Arends, et al.
Trials|June 24, 2020
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trialBastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, et al.
Trials|June 24, 2020
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trialCedric Bosteels, Bastiaan Maes, Karel Van Damme, et al.
Rheumatology (Oxford, England)|December 1, 2021
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritisAnn-Sophie De Craemer, Thomas Renson, Liselotte Deroo, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|October 6, 2022
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
Seminars in Arthritis and Rheumatism|July 30, 2022
Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's SyndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
RMD Open|October 24, 2025
Ultrasound-guided core needle biopsy of the parotid gland in Sjögren's disease: a promising tool towards precision medicineHelena Achten, Eva Genbrugge, Liselotte Deroo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 30, 2024
Impact of IgG Fc Glycosylation on Disease Dynamics in Patients With Primary Sjögren DiseaseHelena Achten, Leander Meuris, Liselotte Deroo, et al.
Trials|June 5, 2020
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trialBastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, et al.
Trials|June 7, 2020
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trialCedric Bosteels, Bastiaan Maes, Karel Van Damme, et al.
Annals of the Rheumatic Diseases|April 17, 2026
Efgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO)Isabelle Peene, Gwenny M Verstappen, Suzanne Arends, et al.
Trials|June 24, 2020
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trialBastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, et al.
Trials|June 24, 2020
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trialCedric Bosteels, Bastiaan Maes, Karel Van Damme, et al.
Rheumatology (Oxford, England)|December 1, 2021
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritisAnn-Sophie De Craemer, Thomas Renson, Liselotte Deroo, et al.
Pageof 3